- Home
- BHAT vs SILO Comparison
BHAT vs SILO Comparison
Compare BHAT & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHAT | SILO |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Apparel |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.1M | 8.0M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BHAT | SILO |
|---|---|---|
| Price | $1.44 | $0.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 45.3K | ★ 132.6K |
| Earning Date | 11-26-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $18,972,415.00 | $72,102.00 |
| Revenue This Year | N/A | $1.86 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.07 | $0.36 |
| 52 Week High | $24.50 | $3.37 |
Technical Indicators
Market Signals| Indicator | BHAT | SILO |
|---|---|---|
| Relative Strength Index (RSI) | 54.27 | 36.38 |
| Support Level | $1.19 | $0.42 |
| Resistance Level | $1.60 | $0.46 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 60.00 | 6.32 |
Price Performance
Historical ComparisonAbout BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.